1-3 of 3
Michael Grondine
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly Effective in ER+ Breast Cancer When Administered Using Intermittent or Continuous Schedules

Free
Sylvie M. Guichard, Jon Curwen, Teeru Bihani, Celina M. D'Cruz, James W.T. Yates, Michael Grondine, Zoe Howard, Barry R. Davies, Graham Bigley, Teresa Klinowska, Kurt G. Pike, Martin Pass, Christine M. Chresta, Urszula M. Polanska, Robert McEwen, Oona Delpuech, Stephen Green, Sabina C. Cosulich
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2015) 14 (11): 2508–2518.
https://doi.org/10.1158/1535-7163.MCT-15-0365
Published: 03 November 2015
View article titled, AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly Effective in ER+ Breast Cancer When Administered Using Intermittent or Continuous Schedules
Open the PDF for AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly Effective in ER+ Breast Cancer When Administered Using Intermittent or Continuous Schedules in another window
Includes: Supplementary data
Journal Articles

Abstract A146: Preclinical models relevant to the treatment of post-menopausal breast cancer.

Free
Ermira Pazolli, Anne Marie Mazzola, Jon Curwen, Hazel Weir, Casey Kiessel, Michael Grondine, Celina D'Cruz, Mike Zinda
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): A146.
https://doi.org/10.1158/1535-7163.TARG-13-A146
Published: 01 November 2013
View article titled, Abstract A146: Preclinical models relevant to the treatment of post-menopausal breast cancer.
Journal Articles

Preclinical identification of AZD7762, a novel, potent and selective inhibitor of Checkpoint kinases

Free
Susan Ashwell, Benjamin Caleb, Chun Deng, Stephen Green, Michael Grondine, Heather Haye, Candice Horn, James Janetka, Dongfang Liu, Elizabeth Mouchet, Shannon Ready, Judith Rosenthal, Christophe Queva, Karen Taylor, Adam Sheehy, Graeme Walker, Anne White, Sonya Zabludoff
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): A232.
Published: 01 November 2007
View article titled, Preclinical identification of AZD7762, a novel, potent and selective inhibitor of Checkpoint kinases